Diabetes Care, a research journal of the ADA 🌟
@DiabetesCareADA
Followers
3K
Following
1K
Statuses
2K
The highest-ranked journal devoted exclusively to #diabetes treatment, care, and prevention. 🎙️ #DiabetesCareOnAir Podcast. Also see @Diabetes_ADA @ADA_Pubs.
Joined July 2022
The February 2025 issue of Diabetes Care is now live, featuring the latest scholarly research on #diabetes management & care. 🔗 In this issue: ✨CGM accuracy in hospitalized children ✨The MeMeMe Randomized Trial ✨& more! @ADA_Pubs @AmDiabetesAssn
0
8
7
Both oral and subcutaneously administered GLP-1 RAs demonstrated significant weight, BMI, and waist circumference reduction benefits. This effect may be more significant in patients without diabetes. @ADA_Pubs Read Here➡️
0
3
2
RT @cristinatejerap: Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudin…
0
14
0
RT @cristinatejerap: Screening for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Advanced Fibrosis in Diabetology: A Pro…
0
12
0
RT @ADA_Pubs: 📚Standards of Care in Diabetes—2025 🔎Access Section 3 (free): Prevention or Delay of Type 2 Diabetes and Associated Comorb…
0
1
0
The addition of a type 2 diabetes polygenic risk score to type 2 diabetes family history results in a higher predictive ability for type 2 diabetes than family history alone. @ADA_Pubs Read Here➡️
0
3
7
⭐️Best of #DiabetesCareADA2024⭐️ | #19 ALTMETRIC Association Between Accelerometer-Measured Irregular Sleep Duration and Type 2 Diabetes Risk: A Prospective Cohort Study in the UK Biobank -Sina Kianersi et al. @ADA_Pubs
1
2
3
RT @Ali_Aminian_MD: In @DiabetesCareADA today: In ARMMS-T2D trial, bariatric surgery produced sustained weight loss & improved quality of l…
0
14
0
We developed a novel EHR-driven risk score (D-RISK) to detect undiagnosed dysglycemia. D-RISK performs better than current diabetes screening guidelines and is capable of automation in the EHR. @ADA_Pubs Read Here➡️
0
2
3
RT @DanielJDrucker: The metabolic benefits of metformin evident in short term studies of 30mg prednisone daily for 7 days to healthy lean m…
0
12
0
Microdosing GLP-1RA available in multidose pens can optimize therapy amid challenges in access, affordability, and tolerability but require careful patient selection, counseling, and monitoring. @ADA_Pubs Read Here➡️
0
1
2
0
1
0
RT @ADA_Pubs: 📚Standards of Care in Diabetes—2025 🔎Access Section 2 (free): Classification and Diagnosis of Diabetes 👀
0
8
0
RT @docmaltese: Impact of Diabetes Duration on Functional and Clinical Status in Older Adults With Type 1 Diabetes. @DiabetesCareADA https…
0
7
0
RT @ADA_Pubs: We're live with the February #DiabetesCareOnAir #podcast where hosts Michael R. Rickels, MD, MS, & @AliceYYCheng discuss the…
0
4
0
Monetary intervention approaches are important strategies for improving diabetes outcomes. Next steps include understanding the longitudinal effect of individual and combined approaches on outcomes. @ADA_Pubs Read Here➡️
0
6
6
⭐️Best of #DiabetesCareADA2024⭐️ | #20 ALTMETRIC Timing of Moderate to Vigorous Physical Activity, Mortality, Cardiovascular Disease, and Microvascular Disease in Adults With Obesity -Angelo Sabag et al. @ADA_Pubs
2
2
13
RT @EndocrineToday: 💊Once-daily metformin may help prevent type 2 #diabetes among adults with metabolic syndrome, researchers wrote in a st…
0
7
0
Antiviral treatment reduced the decline of C-peptide in children with T1D one year after diagnosis, but not after two and three years. Further research on the role of antivirals in T1D is required. @ADA_Pubs Read Here➡️
1
11
6
RT @ADA_DiabetesPro: The latest Diabetes Care cover features Sclerotic Siege by Dr. Anil Saxena, a nephrologist & artist. His digital art b…
0
27
0
Subtyping gestational diabetes using insulin secretion and sensitivity helps to more precisely identify children at risk for adverse outcomes, including impaired glucose tolerance and obesity. @ADA_Pubs Read Here➡️
0
31
23